Patient identification and Site Engagement
Success of early phase clinical trials requires finding the right patients and timely study start-up. Through our integrated approach of ongoing site engagement and network relationships, we can help you develop a robust site strategy that meets your enrollment goals and milestones. In this highly specialized and rapidly evolving oncology landscape, the ability to connect with the right sites and patients is critical for the timely completion of trials and the development of innovative therapies.
Find sites with the right investigators, patients and resources
Develop authentic relationships, align priorities between sites and Sponsors
Implement risk mitigation strategies to ensure timely milestone completion
Request more information about our Clinical Trial Services
Contact our experts to help advance your drug development with TD2's Comprehensive Oncology Ecosystem.
Additional Resources
Clinical, Preclinical, Posters and Publications
Leading the way in defining a new Immunotherapy Response Score (IRS) to predict checkpoint inhibitor benefit
Clinical, White Papers
Early Phase Oncology Trial Designs Phase I Strategies Tailored for Success
Videos
TD2 Clinical Capabilities
GET STARTED
Work with a team who believes in your research as much as you do.
Are you ready to accelerate your drug development? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts.